386 related articles for article (PubMed ID: 33315320)
1. [Polyphenols in the treatment of inflammatory bowel diseases].
Chojnacka K; Laskowska J
Postepy Biochem; 2020 Sep; 66(3):256-262. PubMed ID: 33315320
[TBL] [Abstract][Full Text] [Related]
2. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory Effects of Flavonoids in the Prophylaxis and Treatment of Inflammatory Bowel Diseases: A Comprehensive Review.
Ribeiro D; Proenca C; Rocha S; Lima JLFC; Carvalho F; Fernandes E; Freitas M
Curr Med Chem; 2018; 25(28):3374-3412. PubMed ID: 29446723
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
Pearce CB; Duncan HD; Timmis L; Green JR
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
[TBL] [Abstract][Full Text] [Related]
5. Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy.
Fedorak RN; Ismond KP
Dig Dis; 2016; 34(1-2):112-21. PubMed ID: 26982586
[TBL] [Abstract][Full Text] [Related]
6. Phytochemicals and their potential usefulness in inflammatory bowel disease.
Somani SJ; Modi KP; Majumdar AS; Sadarani BN
Phytother Res; 2015 Mar; 29(3):339-50. PubMed ID: 25572840
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
8. Current pharmacotherapy for inflammatory bowel disease.
McKaig BC; Stack WA
Expert Opin Pharmacother; 1999 Nov; 1(1):3-14. PubMed ID: 11249561
[TBL] [Abstract][Full Text] [Related]
9. Terpenes: Modulating anti-inflammatory signaling in inflammatory bowel disease.
Rivera Rodríguez R; Johnson JJ
Pharmacol Ther; 2023 Aug; 248():108456. PubMed ID: 37247693
[TBL] [Abstract][Full Text] [Related]
10. Application of Drug Repurposing Approach for Therapeutic Intervention of Inflammatory Bowel Disease.
Bhat MA; Usman I; Dhaneshwar S
Curr Rev Clin Exp Pharmacol; 2024; 19(3):234-249. PubMed ID: 37859409
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
[TBL] [Abstract][Full Text] [Related]
12. Polyphenol supplementation as a complementary medicinal approach to treating inflammatory bowel disease.
Biasi F; Astegiano M; Maina M; Leonarduzzi G; Poli G
Curr Med Chem; 2011; 18(31):4851-65. PubMed ID: 21919842
[TBL] [Abstract][Full Text] [Related]
13. Current scenario in inflammatory bowel disease: drug development prospects.
Chandel S; Prakash A; Medhi B
Pharmacol Rep; 2015 Apr; 67(2):224-9. PubMed ID: 25712643
[TBL] [Abstract][Full Text] [Related]
14. The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all?
Pineton de Chambrun GP; Torres J; Darfeuille-Michaud A; Colombel JF
Dig Dis; 2012; 30(4):358-67. PubMed ID: 22796797
[TBL] [Abstract][Full Text] [Related]
15. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key.
Dharmani P; Chadee K
Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434
[TBL] [Abstract][Full Text] [Related]
17. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.
Schultz M; Schölmerich J; Rath HC
Dig Dis; 2003; 21(2):105-28. PubMed ID: 14571109
[TBL] [Abstract][Full Text] [Related]
18. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
19. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
20. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]